DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-54.65%
US · US
COIN.US latest organized financial period shows revenue grew +9.4% YoY and net income declined -51.13% YoY. Current price is about 180 USD, while the model base case is about 184 USD; the current price sits -2.4% versus the base case. The page shows both reported and adjusted views; valuation still defaults to reported figures, while adjusted figures help isolate structured one-time-item impact. This summary is intended for public-information research and model review.
Annual financial metrics with switchable views. · Unit: USD
Price date: 2026/04/29 · Updated: 2026/04/29 15:26
Hover each model row to inspect formulas and inputs.
-2.36%
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-54.65%
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
-2.36%
Solves the forward FCF growth rate implied by the current price.
Current price implies roughly 5.6% annualized FCF growth.
Estimates earnings power value without assuming growth.
+155%
Updated: 2026/04/29 15:26
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2023/12/31 | Restructuring charges | Restructuring | -338M USD | Medium |
| 2022/12/31 | Asset sale gain/loss | Asset sale gain/loss | 46K USD | Medium |
| 2022/12/31 | Restructuring charges | Restructuring | -96M USD | Medium |
| 2021/12/31 | Asset impairment | Impairment | -260M USD | Medium |
| 2021/12/31 | Asset sale gain/loss | Asset sale gain/loss | -2M USD | Medium |
| 2020/12/31 | Asset impairment | Impairment | -7M USD | Medium |
| 2020/12/31 | Asset sale gain/loss | Asset sale gain/loss | -561K USD | Medium |
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/12/31 | Annual | 7B USD | 1B USD | - | 2B USD | 4.45 | - |
| 2024/12/31 | Annual | 7B USD | 3B USD | - | 3B USD | 9.48 | - |
| 2023/12/31 | Annual | 3B USD | 95M USD | 433M USD | 923M USD | 0.37 | 1.69 |
| 2022/12/31 | Annual | 3B USD | -3B USD | -3B USD | -2B USD | -11.83 | -11.4 |
| 2021/12/31 | Annual | 8B USD | 4B USD | 4B USD | 11B USD | 14.5 | 15.55 |
Total revenue recognized in each fiscal year.
Adjusted close trend. Current price sample covers: 2025/04/16 - 2026/04/29.